Cancer is a major threat to human life worldwide. Traditional cancer treatments, such as
chemotherapy and surgery, have major limitations and can cause irreversible damage to …

In vitro models are necessary to study the pathophysiology of the disease and the
development of effective, tailored treatment methods owing to the complexity and …

Niosomes are vesicular nanocarriers, biodegradable, relatively non-toxic, stable, and
inexpensive, that provide an alternative for lipid-solid carriers (eg, liposomes). Niosomes …

Aims: This study was aimed to formulate erlotinib (ERL)-loaded transferosomal gel (ERL@
TG) intended for topical application for the treatment of ductal carcinoma in situ. Materials & …

Triple-negative breast cancer (TNBC) is an aggressive subtype with the worst prognosis and
highest recurrence rates. The treatment choices are limited due to the scarcity of endocrine …

We are living in an era of advanced nanoscience and nanotechnology. Numerous
nanomaterials, culminating in nanorobots, have demonstrated ingenious applications in …

Aim: This study aimed to improve the delivery and therapeutic potential of gefitinib (GTB)
against breast cancer by preparing GTB-loaded, nanostructured lipid carriers (GTB-NLCs) …

Nanotechnology-based drug delivery systems, including siRNA, present an innovative
approach to treating breast cancer, which disproportionately affects women. These systems …

Breast cancer is a complex and heterogeneous disease, encompassing various subtypes
characterized by distinct molecular features, clinical behaviors, and treatment responses …

Breast cancer is a complex and heterogeneous disease, encompassing various subtypes
characterized by distinct molecular features, clinical behaviors, and treatment responses …